Article thumbnail

The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

By Hiroaki Bessho, Shigeru Honda, Naoshi Kondo and Akira Negi
Topics: Research Article
Publisher: Molecular Vision
OAI identifier: oai:pubmedcentral.nih.gov:3084225
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.
  2. (2008). Age-related macular degeneration: diagnosis and management.
  3. (2009). Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy. Retina
  4. (2009). ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
  5. (2009). Association of complement factor H and LOC387715 genotypes with response of exudative agerelated macular degeneration to photodynamic therapy. Eye (Lond)
  6. (2010). Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy. Retina
  7. (2008). Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.
  8. CFH and ARMS2 variations in agerelated macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.
  9. (2007). Clinical characteristics of exudative age-related macular degeneration in Japanese patients.
  10. (2010). Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol
  11. (2009). Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture,
  12. (2009). Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population. J Ocul Biol Dis Infor.
  13. (2010). Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci
  14. (2005). Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi
  15. Hyogo Macular Disease Study Group. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo,
  16. (2010). Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study. Acta Ophthalmol.
  17. (2007). LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.
  18. (2010). Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology
  19. (2001). Photodynamic therapy of age-related macular degeneration: History and principles. Semin Ophthalmol
  20. (2011). Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2008; 49:5008-14. [PMID: 18421085] Molecular Vision 2011; 17:977-982 ©
  21. (2008). Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vis
  22. (2009). Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol